miRNA-based biomarkers, therapies, and resistance in Cancer

被引：580

作者：

He, Boxue ^{[1
,2
]}

Zhao, Zhenyu ^{[1
,2
]}

Cai, Qidong ^{[1
,2
]}

Zhang, Yuqian ^{[1
,2
]}

Zhang, Pengfei ^{[1
,2
]}

Shi, Shuai ^{[1
,2
]}

Xie, Hui ^{[1
,2
]}

Peng, Xiong ^{[1
,2
]}

Yin, Wei ^{[1
,2
]}

Tao, Yongguang ^{[1
,2
,3
,4
,5
]}

Wang, Xiang ^{[1
,2
]}

机构：

[1] Cent South Univ, Dept Thorac Surg, Xiangya Hosp 2, Changsha 410011, Hunan, Peoples R China

[2] Cent South Univ, Hunan Key Lab Early Diag & Precis Therapy, Dept Thorac Surg, Xiangya Hosp 2, Changsha 410011, Hunan, Peoples R China

[3] Cent South Univ, Key Lab Carcinogenesis & Canc Invas, Minist Educ, Dept Pathol,Xiangya Hosp, Changsha 410078, Hunan, Peoples R China

[4] Cent South Univ, NHC Key Lab Carcinogenesis, Canc Res Inst, Changsha 410078, Hunan, Peoples R China

[5] Cent South Univ, Sch Basic Med, Changsha 410078, Hunan, Peoples R China

来源：

INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES | 2020年 / 16卷 / 14期

基金：

中国国家自然科学基金;

关键词：

MicroRNAs; Cancer; miRNA-based biomarkers; miRNA-based therapies; Cancer therapy resistance; HEPATOCELLULAR-CARCINOMA CELLS; MINIMALLY INVASIVE BIOMARKER; RNA-BINDING PROTEINS; NONCODING RNA; POSTTRANSCRIPTIONAL REGULATION; TRANSLATION INITIATION; PROMOTES PROLIFERATION; MICRORNA PRECURSORS; CCR4-NOT COMPLEX; MESSENGER-RNAS;

D O I：

10.7150/ijbs.47203

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

MicroRNAs (miRNAs), small non-coding RNAs (ncRNAs) of about 22 nucleotides in size, play important roles in gene regulation, and their dysregulation is implicated in human diseases including cancer. A variety of miRNAs could take roles in the cancer progression, participate in the process of tumor immune, and function with miRNA sponges. During the last two decades, the connection between miRNAs and various cancers has been widely researched. Based on evidence about miRNA, numerous potential cancer biomarkers for the diagnosis and prognosis have been put forward, providing a new perspective on cancer screening. Besides, there are several miRNA-based therapies among different cancers being conducted, advanced treatments such as the combination of synergistic strategies and the use of complementary miRNAs provide significant clinical benefits to cancer patients potentially. Furthermore, it is demonstrated that many miRNAs are engaged in the resistance of cancer therapies with their complex underlying regulatory mechanisms, whose comprehensive cognition can help clinicians and improve patient prognosis. With the belief that studies about miRNAs in human cancer would have great clinical implications, we attempt to summarize the current situation and potential development prospects in this review.

引用

页码：2628 / 2647

页数：20

共 227 条

[51] mRNA Destabilization Is the Dominant Effect of Mammalian MicroRNAs by the Time Substantial Repression Ensues [J].

Eichhorn, Stephen W. ;

Guo, Huili ;

McGeary, Sean E. ;

Rodriguez-Mias, Ricard A. ;

Shin, Chanseok ;

Baek, Daehyun ;

Hsu, Shu-hao ;

Ghoshal, Kalpana ;

Villen, Judit ;

Bartel, David P. .

MOLECULAR CELL, 2014, 56 (01) :104-115

[52]

Eichmuller SB, 2017, JNCI-J NATL CANCER I, V109, P10

[53] Multivalent Recruitment of Human Argonaute by GW182 [J].

Elkayam, Elad ;

Faehnle, Christopher R. ;

Morales, Marjorie ;

Sun, Jingchuan ;

Li, Huilin ;

Joshua-Tor, Leemor .

MOLECULAR CELL, 2017, 67 (04) :646-+

[54] A Human snoRNA with MicroRNA-Like Functions [J].

Ender, Christine ;

Krek, Azra ;

Friedlaender, Marc R. ;

Beitzinger, Michaela ;

Weinmann, Lasse ;

Chen, Wei ;

Pfeffer, Sebastien ;

Rajewsky, Nikolaus ;

Meister, Gunter .

MOLECULAR CELL, 2008, 32 (04) :519-528

[55] miRNA-mediated deadenylation is orchestrated by GW182 through two conserved motifs that interact with CCR4-NOT [J].

Fabian, Marc R. ;

Cieplak, Maja K. ;

Frank, Filipp ;

Morita, Masahiro ;

Green, Jonathan ;

Srikumar, Tharan ;

Nagar, Bhushan ;

Yamamoto, Tadashi ;

Raught, Brian ;

Duchaine, Thomas F. ;

Sonenberg, Nahum .

NATURE STRUCTURAL & MOLECULAR BIOLOGY, 2011, 18 (11) :1211-U52

[56] RETRACTED: Simultaneous overexpression of miR-126 and miR-34a induces a superior antitumor efficacy in pancreatic adenocarcinoma (Retracted Article) [J].

Feng, Shu-De ;

Mao, Ziming ;

Liu, Chunying ;

Nie, Yu-Song ;

Sun, Bin ;

Guo, Minggao ;

Su, Changqing .

ONCOTARGETS AND THERAPY, 2017, 10 :5591-5604

[57] Androgen receptor-modulatory microRNAs provide insight into therapy resistance and therapeutic targets in advanced prostate cancer [J].

Fletcher, Claire E. ;

Sulpice, Eric ;

Combe, Stephanie ;

Shibakawa, Akifumi ;

Leach, Damien A. ;

Hamilton, Mark P. ;

Chrysostomou, Stelios L. ;

Sharp, Adam ;

Welti, Jon ;

Yuan, Wei ;

Dart, Dafydd A. ;

Knight, Eleanor ;

Ning, Jian ;

Francis, Jeffrey C. ;

Kounatidou, Evangelia E. ;

Gaughan, Luke ;

Swain, Amanda ;

Lupold, Shawn E. ;

de Bono, Johann S. ;

McGuire, Sean E. ;

Gidrol, Xavier ;

Bevan, Charlotte L. .

ONCOGENE, 2019, 38 (28) :5700-5724

[58] Most mammalian mRNAs are conserved targets of microRNAs [J].

Friedman, Robin C. ;

Farh, Kyle Kai-How ;

Burge, Christopher B. ;

Bartel, David P. .

GENOME RESEARCH, 2009, 19 (01) :92-105

[59] Tumor microenvironment confers mTOR inhibitor resistance in invasive intestinal adenocarcinoma [J].

Fujishita, T. ;

Kojima, Y. ;

Kajino-Sakamoto, R. ;

Taketo, M. M. ;

Aoki, M. .

ONCOGENE, 2017, 36 (46) :6480-6489

[60] MicroRNA-135a-3p as a promising biomarker and nucleic acid therapeutic agent for ovarian cancer [J].

Fukagawa, Satoshi ;

Miyata, Kohei ;

Yotsumoto, Fusanori ;

Kiyoshima, Chihiro ;

Nam, Sung Ouk ;

Anan, Haruchika ;

Katsuda, Takahiro ;

Miyahara, Daisuke ;

Murata, Masaharu ;

Yagi, Hiroshi ;

Shirota, Kyoko ;

Yasunaga, Shin'ichiro ;

Kato, Kiyoko ;

Miyamoto, Shingo .

CANCER SCIENCE, 2017, 108 (05) :886-896

← 1 2 3 4 5 6 7 8 9 10 →